{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:54:15Z","timestamp":1792662855953,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.tins.2003.08.009","type":"journal-article","created":{"date-parts":[[2003,9,23]],"date-time":"2003-09-23T20:53:17Z","timestamp":1064350397000},"page":"578-580","source":"Crossref","is-referenced-by-count":238,"title":["Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics"],"prefix":"10.1016","volume":"26","author":[{"given":"Luigi","family":"Zecca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio A","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Wilms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sulzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2003.08.009_BIB1","first-page":"359","article-title":"On the origin and significance of neuromelanin","volume":"103","author":"Graham","year":"1979","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.tins.2003.08.009_BIB2","first-page":"713","article-title":"Melanogenesis and extrapiramidal diseases","volume":"23","author":"Cotzias","year":"1964","journal-title":"Fed. Proc."},{"key":"10.1016\/j.tins.2003.08.009_BIB3","first-page":"256","article-title":"Pigmentation in the nucleus substantiae nigrae of mammals","volume":"95","author":"Marsden","year":"1961","journal-title":"J. Anat."},{"key":"10.1016\/j.tins.2003.08.009_BIB4","first-page":"34","article-title":"A spectroscopy study of the equine brain melanins","volume":"36","author":"Cozzi","year":"1985","journal-title":"Archo. Vet. It. (Milano)"},{"key":"10.1016\/j.tins.2003.08.009_BIB5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","article-title":"Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's disease","volume":"24","author":"Duffy","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2003.08.009_BIB6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","article-title":"Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?","volume":"59","author":"Kastner","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB7","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1987","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.tins.2003.08.009_BIB8","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1046\/j.1471-4159.1994.62052030.x","article-title":"Neuromelanin of the human substantia nigra: a mixed-type melanin","volume":"62","author":"Odh","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1471-4159.2003.01917.x","article-title":"The structure of neuromelanin as studied by chemical degradative methods","volume":"86","author":"Wakamatsu","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB10","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1046\/j.1471-4159.2000.0741758.x","article-title":"Interaction of human substantia nigra neuromelanin with lipids and peptides","volume":"74","author":"Zecca","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0014-5793(99)01001-7","article-title":"The structure of neuromelanin and its iron binding site studied by infrared spectroscopy","volume":"457","author":"Bridelli","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2003.08.009_BIB12","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1046\/j.1471-4159.2000.0752583.x","article-title":"Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins","volume":"75","author":"Double","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0306-4522(96)00047-4","article-title":"Interaction of neuromelanin and iron in substantia nigra and other areas of human brain","volume":"73","author":"Zecca","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2003.08.009_BIB14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(96)00308-7","article-title":"Tyrosinase mRNA is expressed in human substantia nigra","volume":"45","author":"Xu","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.tins.2003.08.009_BIB15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0169-328X(97)00301-X","article-title":"New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain","volume":"53","author":"Tief","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.tins.2003.08.009_BIB16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0304-3940(98)00649-1","article-title":"Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?","volume":"253","author":"Ikemoto","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2003.08.009_BIB17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00005072-195810000-00005","article-title":"On the nature of pigment granules in the cell of the locus coeruleus and substantia nigra","volume":"17","author":"Foley","year":"1958","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2003.08.009_BIB18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB19","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1074\/jbc.274.6.3268","article-title":"Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines","volume":"274","author":"Matsunaga","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2003.08.009_BIB20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0028-3908(86)90242-X","article-title":"Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species","volume":"25","author":"Fornstedt","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tins.2003.08.009_BIB21","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2003.08.009_BIB22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3080808","article-title":"Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin","volume":"231","author":"D'Amato","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.tins.2003.08.009_BIB23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(88)90002-X","article-title":"Autoradiography of 14C paraquat or 14C diquat in frogs and mice: accumulation in neuromelanin","volume":"93","author":"Lindquist","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2003.08.009_BIB24","first-page":"2403","article-title":"Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules","volume":"37","author":"Salazar","year":"1978","journal-title":"Fed. Proc."},{"key":"10.1016\/j.tins.2003.08.009_BIB25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.1994.62031097.x","article-title":"Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain","volume":"62","author":"Zecca","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(92)91334-B","article-title":"Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study","volume":"593","author":"Good","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2003.08.009_BIB27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1471-4159.1992.tb08362.x","article-title":"Iron\u2013melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis","volume":"59","author":"Jellinger","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0925-4439(95)00058-C","article-title":"The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems","volume":"1271","author":"Zareba","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tins.2003.08.009_BIB29","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2003.08.009_BIB30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0925-4439(99)00116-7","article-title":"Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients","volume":"1500","author":"Lopiano","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tins.2003.08.009_BIB31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0891-5849(96)00623-5","article-title":"Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study","volume":"23","author":"Shima","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tins.2003.08.009_BIB32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3940(86)90614-2","article-title":"Neuromelanic pigment in substantia nigra neurons of rats and dogs","volume":"72","author":"DeMattei","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2003.08.009_BIB33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.18.8.817","article-title":"Studies on neuromelanin. II. Melanin in the brainstems of infants and children","volume":"18","author":"Fenichel","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2003.08.009_BIB34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","article-title":"The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease","volume":"510","author":"Zecca","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2003.08.009_BIB35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2003.08.009_BIB36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2003.08.009_BIB37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.02-0314fje","article-title":"Activation of microglia by human neuromelanin is NF-\u03baB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease","volume":"17","author":"Wilms","year":"2003","journal-title":"FASEB J."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223603002832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223603002832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T18:23:30Z","timestamp":1550859810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223603002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0166223603002832"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2003.08.009","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}